Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administeredBy |
immune response
|
| gptkbp:approvedBy |
2017
malaria prevention herpes zoster prevention |
| gptkbp:component |
liposome-based adjuvant
|
| gptkbp:contains |
gptkb:QS-21
gptkb:MPL lipids cholesterol DOPC MPL (3-O-desacyl-4'-monophosphoryl lipid A) QS-21 (saponin extract from Quillaja saponaria) |
| gptkbp:developedBy |
GlaxoSmithKline
|
| https://www.w3.org/2000/01/rdf-schema#label |
AS01
|
| gptkbp:mechanismOfAction |
stimulates immune response
|
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:usedIn |
gptkb:Shingrix_vaccine
RTS,S malaria vaccine |
| gptkbp:bfsParent |
gptkb:RTS,S/AS01
|
| gptkbp:bfsLayer |
5
|